Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial

Overview of attention for article published in Alzheimer's Research & Therapy, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 23 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial.

Alzforum, 03 Feb 2023

Wunderlich G, Blahova Z, Garcia M, Jessen F. Alzheimers Res Ther. 2023 Jan 28;15(1):24.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.